Member Exclusive

€3 million investment into small molecules for muscle regeneration

Anagenesis Biotechnologies has received a €3 million investment by the Boehringer Ingelheim Venture Fund and Cap Innov’Est.

Go to the profile of Freya Leask
Dec 06, 2018
0
0

Please sign in or register for FREE

No comments yet.